1 May 2024 false No description of principal activity Taxfiler 2024.6 true 13363117 business:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 13363117 2024-04-30 13363117 2024-05-01 2025-04-30 13363117 business:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 13363117 business:FilletedAccounts 2024-05-01 2025-04-30 13363117 2025-04-30 13363117 business:Director1 2024-05-01 2025-04-30 13363117 business:Director2 2024-05-01 2025-04-30 13363117 business:RegisteredOffice 2024-05-01 2025-04-30 13363117 2024-04-30 13363117 core:WithinOneYear 2025-04-30 13363117 core:WithinOneYear 2024-04-30 13363117 core:AfterOneYear 2025-04-30 13363117 core:AfterOneYear 2024-04-30 13363117 core:ShareCapital core:PreviouslyStatedAmount 2025-04-30 13363117 core:ShareCapital core:PreviouslyStatedAmount 2024-04-30 13363117 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-04-30 13363117 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-04-30 13363117 core:PreviouslyStatedAmount 2025-04-30 13363117 core:PreviouslyStatedAmount 2024-04-30 13363117 business:SmallEntities 2024-05-01 2025-04-30 13363117 countries:EnglandWales 2024-05-01 2025-04-30 13363117 core:ComputerEquipment 2024-05-01 2025-04-30 13363117 core:IntangibleAssetsOtherThanGoodwill 2024-04-30 13363117 core:IntangibleAssetsOtherThanGoodwill 2024-05-01 2025-04-30 13363117 core:IntangibleAssetsOtherThanGoodwill 2025-04-30 13363117 core:ComputerEquipment 2024-04-30 13363117 core:ComputerEquipment 2025-04-30 13363117 2023-05-01 2024-04-30 iso4217:GBP xbrli:pure
Company Registration No. 13363117 (England and Wales)
Key Performance International Healthcare Ltd Unaudited accounts for the year ended 30 April 2025
Key Performance International Healthcare Ltd Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Key Performance International Healthcare Ltd Company Information for the year ended 30 April 2025
Directors
Gary Sheridan Matthew Heslam
Company Number
13363117 (England and Wales)
Registered Office
11 Church Road Bexleyheath DA7 4DD England
Accountants
Griffin and Sage Limited 172 Park Road Peterborough PE1 2UF
- 3 -
Key Performance International Healthcare Ltd Statement of financial position as at 30 April 2025
2025
2024
Notes
£
£
Fixed assets
Intangible assets
4
217,928
51,175
Tangible assets
5
19,660
13,391
Investments
6
425
425
238,013
64,991
Current assets
Debtors
7
2,028,319
3,246,591
Cash at bank and in hand
86,398
53,171
2,114,717
3,299,762
Creditors: amounts falling due within one year
8
(1,766,538)
(2,724,102)
Net current assets
348,179
575,660
Total assets less current liabilities
586,192
640,651
Creditors: amounts falling due after more than one year
9
(160,000)
(359,341)
Net assets
426,192
281,310
Capital and reserves
Called up share capital
176
176
Profit and loss account
426,016
281,134
Shareholders' funds
426,192
281,310
For the year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 6 July 2026 and were signed on its behalf by
Matthew Heslam Director Company Registration No. 13363117
- 4 -
Key Performance International Healthcare Ltd Notes to the Accounts for the year ended 30 April 2025
1
Statutory information
Key Performance International Healthcare Ltd is a private company, limited by shares, registered in England and Wales, registration number 13363117. The registered office is 11 Church Road, Bexleyheath, DA7 4DD, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
25% Reducing Balance
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
Freehold investment property
Investment properties are revalued annually and any surplus or deficit is dealt with through the profit and loss account. No depreciation is provided in respect of investment properties.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
- 5 -
Key Performance International Healthcare Ltd Notes to the Accounts for the year ended 30 April 2025
Going concern
These financial statements show a profit before tax for the financial period ended 30 April 2025 of £444,388 (2024: £604,960) and equity of £426,016 (2024: £281,310). The financial statements have been prepared on a going concern basis, which the directors consider to be appropriate. Whilst the directors acknowledge the challenging trading environment, including ongoing pressures arising from reductions in NHS funding and the broader economic climate, the Company continues to trade profitably and has maintained a positive equity position. The directors are confident that the Company has adequate financial resources to continue in operational existence for the foreseeable future. In reaching this conclusion, the directors have considered the Company's continued profitability, its accumulated reserves, and the availability of continuing financial support from Shareholders for a period of at least 12 months from the date of approval of these financial statements. Liquidity risk will continue to be actively monitored and managed.
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases, the debtors are stated at cost less impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and in hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less and bank overdrafts. In the statement of financial position, bank overdrafts are shown within borrowings or current liabilities. In the Statement of Cash Flows, cash and cash equivalents are shown net of bank overdrafts that are repayable on demand and form an integral part of the company's cash management.
Trade and other creditors
Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
- 6 -
Key Performance International Healthcare Ltd Notes to the Accounts for the year ended 30 April 2025
Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period. Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable temporary differences Deferred tax assets are generally recognised for all deductible timing differences to the extent that it is probable that taxable profits will be available against which those deductible temporary differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. The measurement of deferred tax liabilities and assets reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities. Current or deferred tax for the year is recognised in profit or loss, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
Financial Instruments
The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities such as trade and other accounts receivable and payable, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares. Debt instruments, like loans and other accounts receivable and payable, are initially measured at present value of the future payments and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade payables or receivables, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration, expected to be paid or received. However if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in case of an outright short term loan not at market rate, the financial asset or liability is measured, initially and subsequently, at the present value of the future payment discounted at a market rate of interest for a similar debt instrument. Investments in non-convertible preference shares and non-puttable ordinary and preference shares are measured: • At fair value with changes recognised in the Income Statement if the shares are publicly traded or their fair value can otherwise be measured reliably; • At cost less impairment for all other investments. Financial assets, are assessed for indicators of impairment at the end of each reporting period. Financial assets are considered to be impaired when there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows of the investment have been affected. For all other financial assets, objective evidence of impairment could include: • significant financial difficulty of the issuer or counterparty; or • breach of contract, such as a default or delinquency in interest or principal payments; or • it becoming probable that the borrower will enter bankruptcy or financial re-organisation; or • the disappearance of an active market for that financial asset because of financial difficulties. For certain categories of financial asset, such as trade receivables, assets that are assessed not to be impaired individually are,
- 7 -
Key Performance International Healthcare Ltd Notes to the Accounts for the year ended 30 April 2025
in addition, assessed for impairment on a collective basis. Objective evidence of impairment for a portfolio of receivables could include the Company's past experience of collecting payments, an increase in the number of delayed payments in the portfolio past the average credit period of 50 days, as well as observable changes in national or local economic conditions that correlate with default on receivables. For financial assets carried at amortised cost, the amount of the impairment loss recognised is the difference between the asset's carrying amount and the present value of estimated future cash flows, discounted at the financial asset's original effective interest rate. For financial assets carried at cost, the amount of the impairment loss is measured as the difference between the asset's carrying amount and the present value of the estimated future cash flows discounted at the current market rate of return for a similar financial asset. Such impairment loss will not be reversed in subsequent periods. The carrying amount of the financial asset is reduced by the impairment loss directly for all financial assets with the exception of trade receivables, where the carrying amount is reduced through the use of an allowance account. When a trade receivable is considered uncollectible, it is written off against the allowance account. Subsequent recoveries of amounts previously written off are credited against the allowance account. Changes in the carrying amount of the allowance account are recognised in profit or loss. For financial assets measured at amortised cost, if, in a subsequent period, the amount of the impairment loss decreases and the decrease can be related objectively to an event occurring after the impairment was recognised, the previously recognised impairment loss is reversed through profit or loss to the extent that the carrying amount of the investment at the date the impairment is reversed does not exceed what the amortised cost would have been had the impairment not been recognised.
Finance costs
Finance costs are charged to the Income Statement over the term of the debt using the effective interest rate method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.
Interest bearing borrowings
Interest-bearing borrowings are recognised initially at fair value less attributable transaction costs. Subsequent to initial recognition, interest-bearing borrowings are stated at amortised cost with any difference between the amount initially recognised and redemption value being recognised in the statement of comprehensive income over the period of the borrowings, together with any interest and fees payable, using the effective interest method.
Defined contribution pensions
The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payments obligations. The contributions are recognised as an expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the company in independently administered funds.
Provisions
Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation. Provisions are charged as an expense to the Income Statement in the year that the Company becomes aware of the obligation, and are measured at the best estimate at the Statement of Financial Position date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties. When payments are eventually made, they are charged to the provision carried in the Statement of Financial position.
- 8 -
Key Performance International Healthcare Ltd Notes to the Accounts for the year ended 30 April 2025
Related Parties
For the purposes of these financial statements, a party is considered to be related to the Company if: • the party has the ability, directly or indirectly, through one or more intermediaries, to control the Company or exercise significant influence over the company in making financial and operating policy decisions, or has joint control over the Company; • the Company and the party are subject to common control; • the party is an associate of the Company or a joint venture in which the Company is a venturer; • the party is a member of key management personnel of the Company or the Company’s parent, or a close family member of such an individual, or is an entity under the control, joint control or significant influence of such individuals; • the party is a close family member of a party referred to in (i) or is an entity under the control, joint control or significant influence of such individuals; or • the party is a post-employment benefit plan which is for the benefit of employees of the Company or of any entity that is a related party of the Company. Close family members of an individual are those family members who may be expected to influence, or be influenced by, that individual in their dealings with the entity.
4
Intangible fixed assets
Other
£
Cost
At 1 May 2024
51,175
Additions
190,967
At 30 April 2025
242,142
Amortisation
At 1 May 2024
-
Charge for the year
24,214
At 30 April 2025
24,214
Net book value
At 30 April 2025
217,928
At 30 April 2024
51,175
5
Tangible fixed assets
Computer equipment
£
Cost or valuation
At cost
At 1 May 2024
25,260
Additions
16,779
At 30 April 2025
42,039
Depreciation
At 1 May 2024
11,869
Charge for the year
10,510
At 30 April 2025
22,379
Net book value
At 30 April 2025
19,660
At 30 April 2024
13,391
- 9 -
Key Performance International Healthcare Ltd Notes to the Accounts for the year ended 30 April 2025
6
Investments
Subsidiary undertakings
£
Valuation at 1 May 2024
425
Valuation at 30 April 2025
425
7
Debtors
2025
2024
£
£
Amounts falling due within one year
Trade debtors
1,251,481
2,187,866
Amounts due from group undertakings etc.
306,779
-
Accrued income and prepayments
452,362
961,437
Other debtors
17,697
97,288
2,028,319
3,246,591
8
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
473,536
1,542,971
Trade creditors
870,261
644,703
Taxes and social security
81,478
172,014
Other creditors
21,773
6,916
Accruals
319,490
357,498
1,766,538
2,724,102
9
Creditors: amounts falling due after more than one year
2025
2024
£
£
Amounts owed to group undertakings and other participating interests
-
72,486
Other creditors
160,000
286,855
160,000
359,341
10
Transactions with related parties
Mr M Heslam and Mr J Henderson have provided a joint and several personal guarantee, limited to £250,000 in respect of obligations of the company to SME invoice Finance Ltd. Other borrowings include an interest free loan from Mr J Henderson amounting to £178,200 (2024: £284,584). Mr J Henderson is not permitted to withdraw £160000 (2024: £160,000) of this loan without SME Invoice Finance Limited approval, this amount is disclose as amount falling due after more than one year.
11
Average number of employees
During the year the average number of employees was 24 (2024: 17).
- 10 -